| Evaluation of Type C Hospital Formularies in Yogyakarta |
Anggriani Y, Suryawati S, Pudjaningsih D
 Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Do Village Revolving Funds Improve Access and Rational Use of Drugs in Laos? |
Bigdeli M, Ketsouvannasane B, Shuey DA
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Promoting Drug and Therapeutics Committees in the Developing World |
Green T, Holloway K.A., Chalker J.
Poster presentation
Abstract
Oral Presentation 1
Oral presentation 2 |
|
|
|
|
|
| Accessibility, Pattern of Use and Implications of Restricted Availability of Medicines for Treatment of Substance Abuse in a Tertiary Level Health Care Center in North Eastern India |
Chakrabarti A, Dutta S
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Changes in Antiretroviral Therapy and in Outcomes of HIV/AIDS Patients in Taiwan before and after a New HIV/AIDS Therapy Reimbursement Scheme |
Chang H
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Scoring System for the Development of the National List of Essential Drugs (NLED) in Thailand |
Chongtrakul P
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Do Fixed-Dose Pills or Unit-of-Use Packaging Improve Adherence? A Systematic Review |
Connor J, Rafter NJ, Rodgers A
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Effect of a Regulatory Intervention on Drug Availability in Nepal |
Dangechhetri G, Kafle KK, Karkee SB, Bhuju GB, Shrestha BM, Rajbhandari V, Humagain B
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Adverse Events Associated with Turmeric Preparations: Consumer Reporting Experience |
Suwankesawong W
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Empowering Stakeholders in Drug Policy Making by Research Evidence to Improve Regulations for Ethical Drug Advertisements toward Rational Drug Use |
Dung PH, Nguyen Thi Kim, Chuc NTK and Nguyen Thi Minh Hieu
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Pharmacy Practices of Dispensing Doctors in Zimbabwe |
Hansen E, Trap B
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Quality of Drug Advertisements Following the Deregulation of Mass Media in Indonesia |
Hidayati S, Munawaroh S, Saleh-Danu S
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Impact on Prescribing Patterns of a Fee per Drug Unit versus a Fee per Drug Item |
Holloway K, Karkee SB, Tamang AL, Gurung YB, Pradhan R
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Impact of a Cost Sharing Drug Supply Scheme on the Quality of Care in Public Primary Health Care Facilities in Rural Eastern Nepal |
Holloway K, Gautam BR
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| ABC Analysis in Hospitals of the National Capital Territory of Delhi: Impact of Drug Policy |
Khanna N, Tekur U, Bapna JS
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Improving Rational Use through Efficient Procurement. Review of the Existing Evidence Base to Guide Essential Medicine Procurement |
Levison L, Laing R, Waning B, Kaplan W
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Cost as a Barrier to Access: Identifying the Component Costs of Essential Medicines |
Levison L, Laing R
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Accessibility to Inhaled Corticosteroids among Adults with Chronic Asthma: An Impact of the Universal Health Care Coverage Policy |
Limwattananon C, Limwattananon S, Pannarunothai S
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Rapid Penetration of Cox2 Inhibitors in the Non-Steroidal Anti-inflammatory Drug Market: An Implication for Hospital Cost Containment Policies |
Limwattananon S, Limwattananon C, Pannarunothai S
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Study of Rational Drug Use Profiles in an Non-Government Organization (NGO)-Managed Health Center versus Private Health Practitioners |
Mandal S, Mandal M
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| The Practice of Dispensing Prescribers: A Threat to Appropriate Medicines Use? |
Trap B, Hansen EH
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| The Role of a Comprehensive Pharmaceutical Sector Development Programme in Improving Rational Use of Drugs: The Ghana Example |
Ofori-Adjei D, Gyansa-Lutterodt M, Asiama D, Dodoo A, Aboagye-Nyame F, Osafo E, Arhinful D
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Improving Economic Prescribing in a Teaching Hospital through an Educational Strategy to Promote Generic Prescribing |
Suttipoom P, Anansakunwatt W, Ngamthipwatthana T, Wagner A, Ross-Degnan D
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Improving Access to Essential Medicines through Public-Private Initiatives: The Case of the Catholic Pharmaceutical Service in Ghana |
Osafo E, Buckle G, Staley R, Allotey C, Oppong-Tawiah B, Bonnah S, Annan I, Eghan K
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Reducing Codeine Cough Syrup Medicine Consumption to Control Codeine Abuse in Thailand |
Patcharapisarn N
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Evidence, Cost and Decision Making Criteria Used by Provincial Pharmacy and Therapeutics Committees in South Africa |
Pillay T, Hill SR, Walkom E
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Drug Database and Performance Indicators for Utilization Monitoring |
Pongcharoensuk P, Angsanant M, Chantrakunopars P, Phuthong P, Kongsawat S
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| A Pilot Study Examining Criteria Used to Select Drugs for Hospital, Provincial and National Formularies |
Robertson J, Newby D, Pillay A, Walkom E
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Evaluating Australia's National Strategy for Quality Use of Medicines: Results of Indicator Measurements 1992-2003 |
Roughead L, Semple SJ
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Assessment of Local Purchase of Pharmaceuticals at Public Health Facilities |
Saparyono B, Suryawati S
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform |
Sripairoj A, Tangcharoensathien V, Liamputtong P
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Impact of Training in Drug Supply Management (DSM) on DSM, Dispensing Practices, and Patient Knowledge and Care at Primary Health Care (PHC) Clinics |
Summers R, Kruger CH
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Impact Assessment of Supervision on Medicines Management |
Trap B, Todd CH, Moore H, Laing R
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Economic Analysis of Drug Expenditure in the Government Medical College Hospital, Nagpur, India |
Thawani V, Turankar AV, Sontakke SD, Pimpalkhute SV, Dakhale GN, Jaiswal KS, Gharpure KJ
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Quality Assurance of Medicines under the Universal Health Coverage Program in Thailand |
Tiptaradol S, Abhigantaphand Duangporn, Ungboriboonpisal Sooks
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Developing National Formularies Based on the WHO Model Formulary |
Tisocki K, Laing R, Hogerzeil H, Mehta DK, Ryan RS
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Improving Performance of Drug and Therapeutics Committees in Laos |
Vang C, Wahlstrom R, Tomson G, Kounvong S, Southammavong T
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Assessment of the Selection Process for the 2003 National List of Essential Drugs (NLED) of Thailand |
Yoongthong W, Kunaratanapruk S, Sumpradit N, Chongtrakul P
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Educational Intervention to Improve Prescribing Habits of Pediatricians in Treatment of Uncomplicated Acute Upper Respiratory Tract Infection |
Ziganshina L, Pikuza OI, Magsumova DR, Galyautdinova AYu
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Building the National Drug Policy on Evidence: Assessing Implementation in Lao PDR |
Paphassarang C, Wahlström R, Phoummalaysith B, Boupha B, Tomson G
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Impact of the Tamil Nadu Medical Services Corporation on Drug Prescribing in Primary Health Care |
Murali R, Sathyanarayanan D, Rajkumar C, Senthil Kumar.R, Usha Titus
Poster presentation
Abstract
Oral Presentation 1
Oral presentation 2 |
|
|
|
|
|
| Discrepancies between International and National Lists of Essential Reproductive Health Medicines |
Jayasekar S, Gray R, Hogerzeil H V, Jayasekar S, Usher-Patel M
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Improving Access and Use of Medicines through Private Sector Initiatives: A Case for an Essential Medicines Franchise in Ghana. |
Eghan K, Marsden A., Staley R, Idun J, Bruce E
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Quasi-Experimental Study Designs in Evaluating Medicine Use Interventions |
Matowe L, Ramsay C
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Establishing Effective Hospital Drug and Therapeutics Committees: A Situational Analysis |
Ndhlovu C, Simoyi T
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Accredited Drug Dispensing Outlets: Improving Access to Quality Drugs and Services in Rural and Peri-Urban Areas with Few or No Pharmacies |
Sigonda-Ndomondo M, Heltzer N, Clark M, Mbwasi R, Shirima R
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Effect of an Educational Intervention on the Drug Purchasing Practices of Local Government Officials in a Decentralized Setting: Quasi-Experimental Study with Control |
Juban N, Sia IC, Torres CE
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Pharmacists’ Perceptions of the Development of the Herbal Medicines Market in Iran |
Asghari G
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| A Longitudinal Policy Analysis of the Impact on Prescribing Patterns and Medication Cost of a Generic Dispensing Policy in a Teaching Hospital in Thailand |
Anansakunwatt W, Suttipoom P, Wagner A
Poster presentation
Abstract
Oral Presentation 1
Oral presentation 2 |
|
|
|
|
|
| The WHO/HAI Drug Promotion Database |
Herxheimer A, Lexchin J
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Impact of an NGO-Supported Supervisory Program on Quality of Care in Private Drug Shops in Rural East Nepal |
Holloway K, Gautam BR
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Development of Essential Drugs Lists in Four Central Asian Republics (Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan): Comparison and Discrepancies |
Jafarov A, Laing R
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| The Effects of Managerial Intervention on Drug Prescribing Patterns at King Chulalongkorn Memorial Hospital |
Limpanathikul W, Wangsaturaka D, Nantawan P, Itthipanichapong C
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Treating AIDS: Dilemmas of Unequal Access in Uganda |
Whyte S, Whyte MA, Meinert L, Kyaddondo B
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Experiences in South Africa with the Introduction of Pharmaceutical Pricing Legislation |
Zokufa H, Pillay T
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Prequalification of HIV/AIDS Products and Manufacturers as Part of the Procurement, Quality, and Sourcing Project: Access to HIV/AIDS Drugs of Acceptable Quality |
Van Zyl A, Gross O, Rägo L, Tasevska I
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Differential Pricing of Pharmaceuticals: What About the Rest of the World? |
Lang D, Hill S
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Overview of Key Medicines Issues and Challenges, Measuring Use of Medicines: How Have We Progressed in the Last Decade |
Holloway K, Ivanovska V
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Does Drug Use Evaluation (DUE) Required by National Policy Improve Use of Medicines? |
Akaleephan C, Sittitanyakit B, Muenpa R
Poster presentation
Abstract
Oral Presentation 1 |
|
|
|
|
|
| Attitude and Perceptions of Stakeholders on Decentralization of Health Services in Uganda: The Case of Lira and Apac Districts |
Anokbonggo W, Ogwal-Okeng J W, Ross-Degnan D
Poster presentation
Abstract |
|
|
|
|
|
| Interventions in the Kosovo Pharmaceutical Sector: Success or Failure? |
Arifaj-Blumi D
Poster presentation
Abstract |
|
|
|
|
|
| Indicators for Medicines Information Services in Developing Countries |
Ball D, Tagwireyi D
Poster presentation
Abstract |
|
|
|
|
|
| Relevance of Undertaking Expenditure Reviews to Inform Decision Making |
Beaver C
Poster presentation
Abstract |
|
|
|
|
|
| Impact of Drug Policy on Improving Access to Medicines in Delhi |
Bhoi N, Roy Chaudhury R, Bapna JS, Tekur U, Khanna N
Poster presentation
Abstract |
|
|
|
|
|
| Provida’s Impact on Improving Access to and Use of Essential Drugs in Poor Communities in Peru |
Castro J, Solari J
Poster presentation
Abstract |
|
|
|
|
|
| Impact of Implementation of the Delhi Drug Policy on Availability, Accessibility, Quality of Drugs and Prescribing Patterns (1995-2002) |
Roy Chaudhury R, Parameswar R, Gupta U, Sharma S, Tekur U, Bapna JS
Abstract |
|
|
|
|
|
| Access to Medicine in Iran |
Cheraghali M
Poster presentation
Abstract |
|
|
|
|
|
| Rational Use and Improved Access to Opioid Analgesics -- Has The Time Come? |
Foster S
Abstract |
|
|
|
|
|
| Drug Pricing and Availability in Karaganda, Kazakhstan |
Gulaev A, Laing R, Muratov S, Lobyntsev D, Ermekbaeva B, Nurgozhin T, Khe N
Abstract |
|
|
|
|
|
| Qualitative and Quantitative Assessment of the Essential Medicines List of Delhi State: A Time Series Analysis |
Gupta U, Sharma S, Baishya RN, Bapna JS, Chaudhury RR
Poster presentation
Abstract |
|
|
|
|
|
| Monitoring the Pharmaceutical Sector in the Developing World: The Ghana Example |
Gyansa-Lutterodt M, Arhinful D, Addo-Atuah J, Andrews E, Doddo A, Asiamah D, Osei I, Ofori-Adjei D
Poster presentation
Abstract |
|
|
|
|
|
| A Simple Method for Assessing Irrational Prescribing and Prioritizing Prescribing Problems for Intervention: A Pilot Study in Uganda |
Hansen E, Trap B, Anfinnsen M
Poster presentation
Abstract |
|
|
|
|
|
| Project on Enhancement of Research Capacity in Nepal: Interventions in Primary Health Care |
Hansen E, Kafle KK, Karkee SB, Onta SR, Subba S, Sthapit S
Poster presentation
Abstract |
|
|
|
|
|
| Impact of the Essential Drugs Programme at the Primary Health Care Level in South Africa |
Hela M, Zeeman H, Auton MS, Sallet J-P, Summers R, Eagles P
Poster presentation
Abstract |
|
|
|
|
|
| Drug Information in Private Pharmacies in Lao PDR |
Houamboun K, Atxayavong T, Phimmasone B, Simmavong S, Sinhsayachack K, Stålsby Lundborg C, Wahlström R
Poster presentation
Abstract |
|
|
|
|
|
| E-Learning of Public Health Pharmacology |
Huss R, Summers R, Pries K
Poster presentation
Abstract |
|
|
|
|
|
| WHO Prescribing Indicators (1991–1995): Trends and Perspectives in an Outpatient Health Care Facility in Benin City, Nigeria |
Isah A, Isah EC, Aghomo OE
Poster presentation
Abstract |
|
|
|
|
|
| Drug Price Survey along with the WHO/HAI Core List |
Igarashi A, Tsutani K
Poster presentation
Abstract |
|
|
|
|
|
| Availability of Drugs: What Does it Mean in Ugandan Primary Care? |
Jitta J, Whyte SR, Nshakira N
Poster presentation
Abstract |
|
|
|
|
|
| An Analytical Framework for Identifying "Gaps" in Pharmaceutical Research and Development |
Kaplan W, Laing RL
Abstract |
|
|
|
|
|
| Paying for Pharmaceutical Regulation in Developing Countries |
Kaplan W, Laing RL
Poster presentation
Abstract |
|
|
|
|
|
| The Influence of Value Added Tax (VAT) Elimination on Drug Access |
Karymbaeva S
Poster presentation
Abstract |
|
|
|
|
|
| Multi-Country Participatory Evaluation of the Implementation of the WHO Ethical Criteria for Medicinal Drug Promotion: Networking Tools for Monitoring and Evaluation |
Kiatying-Angsulee N, Pham Huy Dung, Sri Hidayati, Khotsay K
Abstract |
|
|
|
|
|
| Developing Tools for Monitoring and Evaluating Unethical Drug Promotion in Thailand |
Kiatying-Angsulee N, Chaisumritchoke S, Chantapasa K, Amrumpai Y
Abstract |
|
|
|
|
|
| Impact of the National Healthcare Reform on Prescribing Patterns of Promotional Targeted Drugs among Thai Physicians |
Layton MR, Chadbunchachai S, Thinkhamrop B, Tangcharoensathien V
Poster presentation
Abstract |
|
|
|
|
|
| Could the WHO Model List of Essential Medicines Do More for the Rational and Safe Use of Injections? |
Logez S, Hutin Y, Holloway K, Robin G, Hogerzeil H
Poster presentation
Abstract |
|
|
|
|
|
| Impact of a National Medicine Policy on Injection Safety and Rational Use of Injections, Burkina Faso 1995-2000 |
Logez S, Hutin Y, Somda P, Thuault J, Holloway K
Poster presentation
Abstract |
|
|
|
|
|
| Impact of a Revolving Drug Fund on Availability of Essential Medicines in Church Health Institutions in Tanzania |
Macatta-Yambi M
Abstract |
|
|
|
|
|
| Interactive Group Discussion: An Intervention to Reduce the Overuse of Injections at Public Health Care Facilities in Cambodia |
Men C
Poster presentation
Abstract |
|
|
|
|
|
| Drug Prescribing Habits in Primary Health Care Facilities and Availability of Drugs in Private and State Pharmacies in the Republic of Serbia |
Moravcevic N, Chiperi A
Poster presentation
Abstract |
|
|
|
|
|
| Managing the Dynamics of Drug Supply, Demand, and Health Service Utilization: A New Rapid Assessment Tool for Forecasting Drug Requirements and Resource Planning (Part 1). |
Nazerali H, Mohamed K, Oteba M, Mwoga J
Poster presentation
Abstract |
|
|
|
|
|
| Monitoring and Assessing a Pharmaceutical Situation: A Comparison of Two Indicator-Based WHO Instruments |
Nurita P, Saparyono, B., Suryawati, S
Poster presentation
Abstract |
|
|
|
|
|
| Impact of Decentralisation on Health Services in Uganda: A Look at Facility Utilisation, Prescribing, and Availability of Essential Drugs |
Ogwal-Okeng J, Anokbonggo WW, Obua C, Ross-Degnan D, Aupont O
Poster presentation
Abstract |
|
|
|
|
|
| The Relationship between Drug Supply and Prescribing Patterns in District Hospitals in Uganda |
Ogwal-Okeng J, Obua C, Anokbonggo W
Poster presentation
Abstract |
|
|
|
|
|
| Assessing Drug Use Practices at Free Medical Camps in Kenya - II |
Orwa J, Ombogo J, Ojoo MA, Oluka M, Ogaja EMA, Wanyanga WO
Poster presentation
Abstract |
|
|
|
|
|
| How Aggressive Recruitment and Training of Pharmacists and Pharmacists’ Assistants is are being Utilized to Improve Management of Drug Supplies |
Peteni L, Qolohle SZ
Poster presentation
Abstract |
|
|
|
|
|
| Operational Guide to Improve Drug Quality in Low-Income Countries |
Phanouvong S, Blum LB, Wondemagegnehu E, Dicken T, Vrakking H, Ssali P, Rahman E, Trin VQ, Smine A, Mahlangu G, Bwire R, Tran D
Abstract |
|
|
|
|
|
| Cost Impact of Using Specific Cyclooxygenase II Inhibitors in Orthopedic Outpatients at Lerdsin Hospital |
Phosri J, Kulsomboon V, Kiatying-Angsulee N
Poster presentation
Abstract |
|
|
|
|
|
| Self-Monitoring Instrument to Improve the Efficiency of Hospital Drug Management |
Pudjaningsih D, Santoso B
Poster presentation
Abstract |
|
|
|
|
|
| Access and Accessibility to Disease Control Tools: A Literature Review |
Radyowijati A, Haak H
Poster presentation
Abstract |
|
|
|
|
|
| Prescribing Practices in Village Health Stations in Rural China |
Ran R, Tomson G
Abstract |
|
|
|
|
|
| “Snap-Lock” Polyethylene Mini Bags for Dispensing Drugs in Sri Lanka |
Senarathna L, Samaranayake A, Kumarage S, Senevirathna A, Kappagoda S.
Poster presentation
Abstract |
|
|
|
|
|
| Progress of Rational Use of Drugs Program in Karnataka, India |
Srinivas C, Sudarshan HC, Bilimagga RS
Poster presentation
Abstract |
|
|
|
|
|
| Perspectives in Postmarket Drug Surveillance: A Review of Adverse Drug Event Reporting Processes |
Subramaniam V, Panasethaned K, Quinn J
Abstract |
|
|
|
|
|
| Decentralization as a Challenge to Improving Drug Management: an Experience from Sleman, Indonesia |
Sunartono H
Poster presentation
Abstract |
|
|
|
|
|
| Producing a Joint WHO/ISDB Practical Guide to Starting or Developing an Independent Drug Bulletin |
Tarr A
Abstract |
|
|
|
|
|
| Review of Public Sector Indicator Studies in Zimbabwe—Who is Paying Attention? |
Tisocki K, Ndhlovu CE, Simoyi T, Wilson E, Goredema W
Poster presentation
Abstract |
|
|
|
|
|
| The Impact on Cost of Care and Use of Medicines of Expanded Drug Coverage via a Positive List in the Philippines |
Valera M, Acuin L, Soria F, Bautista C, Lavina SM
Abstract |
|
|
|
|
|
| Decision Makers and Research in the Laos Pharmaceutical Sector |
Wahlström R, Paphassarang C, Jönsson K, Houamboun K, Akkhavong K, Tomson G
Poster presentation
Abstract |
|
|
|
|
|
| Does Registration of Several Generics Translate into More and Cheaper Drugs for the Patient? |
Fernandopulle B, Senarathna SMDKG
Poster presentation
Abstract |
|
|
|
|
|
| Accessibility of Essential Drugs in Remote Areas of Lao PDR |
Sengaloundeth S, Phachomphonh B, Xayasane S, Phanouvong V, Thammakhanh S, Paphassarang C, Syhakhang L, Eriksson B, Stålsby Lundborg C, Freudenthal S, Tomson G, Wahlström R
Poster presentation
Abstract |
|
|
|
|
|
| The Inappropriate Sale of Medication for Paediatric Use in Siem Reap Province, Cambodia |
Sothearith T, Guhadasan R, Romey E
Poster presentation
Abstract |
|
|
|
|
|
| Evaluation of the Therapeutic Value of Drugs Registered in Peru in 1996 |
Cruzado Ubillús R
Poster presentation
Abstract |
|
|
|
|
|
| Achieving the Ideal: Equity Pricing for Essential Medicines |
Moon S, 't Hoen E, Macé C, Perez-Casas C
Abstract |
|
|
|
|
|
| The Challenge of Integrating an RDU Training Model into the Reality of a Health System Context: A Survey and Coordination Effort in Dar es Salaam, Tanzania |
Wiedenmayer K, Tanner M, Mtasiwa D
Poster presentation
Abstract |
|
|
|
|
|
| Innovative Learning Methods for Rational Drug Prescribing |
Itthipanichpong C, Chompootaweep S, Chongtrakul P, Nantawan P, Thamaree S
Poster presentation
Abstract |
|
|
|
|
|
| Impact of Currency Crisis on Availability, Affordability, and Use of Medicines in Indonesia: A 5-Year Longitudinal Study |
Suryawati S
Poster presentation
Abstract |
|
|
|
|
|
| Drug and Therapeutics Committees in Moldova |
Cebotarenco N, Veltman K, Tchebotarenco S, Shetinina S
Abstract |
|
|
|
|
|
| Drug Use Determinants and Practices in Amman: A Qualitative Study |
Qato D
Poster presentation
Abstract |
|
|
|
|
|
| The Impact of Regulatory Interventions on Pharmaceutical Access and Quality: What Is the Evidence and Where Are the Gaps in Our Knowledge? |
Kaplan W, Laing RL, Waning B, Levison L
Poster presentation
Abstract |
|
|
|
|
|
| Is Local Production of Pharmaceuticals a Way to Improve Pharmaceutical Access in Developing and Transitional Countries? Setting a Research Agenda |
Kaplan W, Laing RL, Foster S, Waning B, Levison L
Abstract |
|
|
|
|
|
| A Pilot Intervention to Improve Injection Practices in the Informal Private Sector in Karachi, Pakistan |
Agboatwalla M, Hutin Y, Luby S , Mussarrat A
Poster presentation
Abstract |
|
|
|
|
|
| Technology Appraisal Programme of the National Institute for Clinical Excellence: A Review by WHO |
de Joncheere K, Hill S, Garattini S , van Loenhout J, O`Brien B
Poster presentation
Abstract |
|
|
|
|
|
| The WHO Essential Medicines Library |
Hogerzeil H, Gray R, Murray E
Poster presentation
Abstract |
|
|
|
|
|
| Assessing the Effect of Two Policy Interventions on Treatment Costs and Drug Use Patterns in a Private Self Funding Healthcare Institution in Nairobi: The Case of Generic Prescribing and Generic Substitution |
Ojoo M, Waning B, Maina M
Poster presentation
Abstract |
|
|
|
|
|
| Access to Essential Medicines as Part of the Fulfillment of the Right to Health |
Hogerzeil H, Vidal C
Poster presentation
Abstract |
|
|
|
|
|
| New Cost Sensitivity Measures to Assess the Impact of User Fees on Physicians' Treatment Choices |
Huttin C, Noyce P, Atella V, Hedvall MB, Weise M, Schafheutl
Abstract |
|
|
|
|
|
| Use of Automated Claims Data in the Kyrgyzstan Outpatient Drug Benefit Program to Evaluate Medicine Pricing Trends Plus Access and Equity among Beneficiaries |
Ibraimova A, Cashin C, Waning B
Abstract |
|
|
|
|
|
| Kyrgyzstan Outpatient Drug (OPD) Benefit Program: Use Of Automated Claims Data to Evaluate the Impact of the OPD Benefit Program on Rational Drug Prescribing by Physicians and Generic Drug Use by Patients |
Kadyrova N, Waning B, Cashin C
Abstract |
|
|
|
|
|
| Outcomes of Introducing the Essential Drugs Concept in Armenia |
Kazaryan I, Melikyan M, Sevikyan A, Vardanyan L
Poster presentation
Abstract |
|
|
|
|
|
| Impact of Availability and Quality of Pharmaceutical Reference Information on Prescribing Habits and Pharmaceutical Expenditure |
Horst H
Poster presentation
Abstract |
|
|
|
|
|
| Impact of Implementation of Clinical Protocols on Rational Drug Use in the Kyrgyz Republic |
Toktobaeva B, Karymbaeva, ST
Poster presentation
Abstract |
|
|
|
|
|
| Using WHO Indicators to Monitor the Implementation of National Drug Policy: Relationship between Country Characteristics and Background, Structure, Process, and Outcome Indicators |
Sjabana D
Poster presentation
Abstract |
|
|
|
|
|
| Improving Access to Essential Medicines in Kenya: The Nyamira District Revolving Drug Fund Experience: |
Ominde-Ogaja E, Boussery G, Otieno G
Poster presentation
Abstract |
|
|
|
|
|
